IL96365A - Preparation for the treatment of inflammatory bowel disorders with C6-2 alkanoic acids - Google Patents

Preparation for the treatment of inflammatory bowel disorders with C6-2 alkanoic acids

Info

Publication number
IL96365A
IL96365A IL9636590A IL9636590A IL96365A IL 96365 A IL96365 A IL 96365A IL 9636590 A IL9636590 A IL 9636590A IL 9636590 A IL9636590 A IL 9636590A IL 96365 A IL96365 A IL 96365A
Authority
IL
Israel
Prior art keywords
acid
composition
present
liter
inflammatory bowel
Prior art date
Application number
IL9636590A
Other languages
English (en)
Hebrew (he)
Other versions
IL96365A0 (en
Original Assignee
Breuer Richard L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Breuer Richard L filed Critical Breuer Richard L
Publication of IL96365A0 publication Critical patent/IL96365A0/xx
Publication of IL96365A publication Critical patent/IL96365A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL9636590A 1989-11-16 1990-11-16 Preparation for the treatment of inflammatory bowel disorders with C6-2 alkanoic acids IL96365A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/438,297 US5039703A (en) 1989-11-16 1989-11-16 Method for treating inflammatory bowel disorders

Publications (2)

Publication Number Publication Date
IL96365A0 IL96365A0 (en) 1991-08-16
IL96365A true IL96365A (en) 1995-06-29

Family

ID=23740078

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9636590A IL96365A (en) 1989-11-16 1990-11-16 Preparation for the treatment of inflammatory bowel disorders with C6-2 alkanoic acids

Country Status (11)

Country Link
US (1) US5039703A (de)
EP (1) EP0502925B1 (de)
AT (1) ATE143261T1 (de)
AU (2) AU6681790A (de)
CA (1) CA2071215C (de)
DE (1) DE69028712T2 (de)
DK (1) DK0502925T3 (de)
ES (1) ES2093695T3 (de)
GR (1) GR3021760T3 (de)
IL (1) IL96365A (de)
WO (1) WO1991007176A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
IT1273628B (it) * 1993-06-04 1997-07-08 Emerging Pharmaceutical Techno Composizioni farmaceutiche per la cura della talassemia contenenti derivati dell'acido butirrico e in particolare isobutirramide
WO1995011699A1 (en) * 1993-10-29 1995-05-04 The Trustees Of Boston University Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
CA2176719C (en) * 1993-11-17 2007-09-18 Geoffrey Anisson Fatty acid delivery system
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
AUPO763197A0 (en) 1997-06-30 1997-07-24 Sigma Pharmaceuticals Pty Ltd Health supplement
AU774861B2 (en) * 1998-02-11 2004-07-08 Douglas V Faller Compositions and methods for the treatment of cystic fibrosis
US6114382A (en) * 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
GB0127916D0 (en) * 2001-11-21 2002-01-16 Rowett Res Inst Method
ITMI20040187A1 (it) * 2004-02-06 2004-05-06 Cosmo Spa Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali
US20070071779A1 (en) * 2005-09-26 2007-03-29 Leggit Ingenuity, Llc Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof
CN102245176B (zh) 2008-10-31 2015-05-27 脂质医药有限公司 用作药物的脂肪酸
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
EP2509418A4 (de) 2009-12-08 2013-03-20 Hemaquest Pharmaceuticals Inc Verfahren und niedrigdosierungspläne zur behandlung von erythrozytendysfunktion
JP4620169B1 (ja) * 2010-01-28 2011-01-26 株式会社三和化学研究所 有機酸重合体を有効成分とするクローン病の予防又は治療剤
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
ES2673276T3 (es) 2013-03-14 2018-06-21 University Of Ottawa Métodos para el diagnóstico y el tratamiento de la enfermedad inflamatoria intestinal
CA2962802A1 (en) * 2014-10-03 2016-04-07 University Of Ottawa Markers for inflammatory bowel disease
US11291693B2 (en) 2015-06-25 2022-04-05 Synlogic Operating Company, Inc. Bacteria engineered to treat metabolic diseases
US20190167615A1 (en) * 2016-08-10 2019-06-06 Monash University Metabolites for treatment and prevention of autoimmune disease
KR102665545B1 (ko) 2017-04-17 2024-05-13 더 유니버서티 오브 시카고 인간 건강에의 적용 및 질환의 치료를 위한 장으로의 단쇄 지방산의 전달을 위한 중합체 재료
KR20220034736A (ko) 2019-05-31 2022-03-18 비락타 서브시디어리 인크. 히스톤 데아세틸라제 억제제를 사용하여 바이러스 관련 암을 치료하는 방법

Also Published As

Publication number Publication date
ATE143261T1 (de) 1996-10-15
EP0502925A1 (de) 1992-09-16
DK0502925T3 (da) 1996-12-23
DE69028712T2 (de) 1997-03-20
EP0502925B1 (de) 1996-09-25
CA2071215C (en) 1997-02-04
GR3021760T3 (en) 1997-02-28
ES2093695T3 (es) 1997-01-01
AU664492B2 (en) 1995-11-16
DE69028712D1 (de) 1996-10-31
EP0502925A4 (en) 1992-12-16
US5039703A (en) 1991-08-13
AU5051693A (en) 1994-01-13
AU6681790A (en) 1991-05-23
IL96365A0 (en) 1991-08-16
WO1991007176A1 (en) 1991-05-30
CA2071215A1 (en) 1991-05-17

Similar Documents

Publication Publication Date Title
US5039703A (en) Method for treating inflammatory bowel disorders
Breuer et al. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis: preliminary report
US4753964A (en) Pharmaceutical compositions of lithium compounds to treat presenile or senile dementia
Wang et al. Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E
Bergan Pharmacokinetic properties of the cephalosporins
AU666782B2 (en) Schizophrenia
DE69928410T2 (de) Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen
Eisen et al. Uric acid metabolism in psoriasis
Yolken et al. Acute fluoride poisoning
KR920000324A (ko) 필수 지방산 처리법
US5569680A (en) Method of treating inflammatory bowel disease with tributyrin
Stewart et al. Further experience with intravesical dimethyl sulfoxide in the treatment of interstitial cystitis
US4910224A (en) Method of modifying the lipid structure and function of cell membranes and pharmaceutical compositions for use therein
Dronfield et al. Zinc in ulcerative colitis: a therapeutic trial and report on plasma levels.
Davies et al. Systemic toxicity from topically applied salicylic acid.
Jones et al. Cathartic-induced magnesium toxicity during overdose management
Davrnovich et al. THE PROGRAMME FOR THE COMPREHENSIVE TREATMENT OF MAXILLOFACIAL PHLEGMONITIS PATIENTS WITH VIRAL HEPATITIS B
KR100450293B1 (ko) 만성장염의치료에유용한알카노일l-카르니틴의용도
US5989558A (en) Method of using rosmarinus officinalis for treating various diseases
Novak et al. Glutamine and other amino acid losses during continuous venovenous hemodiafiltration
Abrahamsson et al. Effect of Short-Term Treatment with Pivalic Acid Containing Antibiotics on Serum Carnitine Concentration-A Risk Irrespective of Age
SEBASTIAN et al. Renal amyloidosis, nephrotic syndrome, and impaired renal tubular reabsorption of bicarbonate
Kornbluth et al. Life-threatening diarrhea after short-term misoprostol use in a patient with Crohn ileocolitis
CN116056715A (zh) 血液净化浓缩物
US4816483A (en) Composition and method for treatment and metaphylaxis of urate and mixed urate lithiasis

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed